Advances in the understanding of the molecular basis of obesity.
Meier
C A
CA
Endocrine Division, Massachusetts General Hospital, Boston, USA.
D000818:Animals; D001835:Body Weight / Q000235:genetics / Q000502:physiology; D003924:Diabetes Mellitus, Type 2 / Q000209:etiology / Q000235:genetics / Q000503:physiopathology; D004195:Disease Models, Animal; D006801:Humans; D007333:Insulin Resistance / Q000502:physiology*; D020738:Leptin; D051379:Mice; D008820:Mice, Obese; D009154:Mutation; D009765:Obesity / Q000188:drug therapy / Q000235:genetics* / Q000503:physiopathology*; D011110:Polymorphism, Genetic; D011506:Proteins / Q000235:genetics / Q000502:physiology* / Q000627:therapeutic use; D011943:Receptors, Adrenergic, beta / Q000235:genetics / Q000502:physiology*; D022702:Receptors, Adrenergic, beta-3; D012527:Satiation / Q000502:physiology*
D020738:Leptin; D011506:Proteins; D011943:Receptors, Adrenergic, beta; D022702:Receptors, Adrenergic, beta-3